News & Events
Ohio Association of Rheumatology (OAR) Annual Meeting
Columbus, OH Healix is excited to exhibit at the upcoming Ohio Association of Rheumatology Annual Meeting on August 23-24, 2019, in Columbus, OH. If you are considering starting your own infusion program or need help managing an existing operation, come and visit...
GI Outlook 2019: The Practice Management Conference
Hollywood, CA Meet the Healix team August 2-4, at the GI Outlook Conference in Hollywood, CA. Visit booth 21 to discover how working with Healix gives you the advantage! For more information on our infusion management services, click...
Healix Infusion Therapy Selected as Limited Distribution Network Partner for Cutaquig®
Healix Infusion Therapy Selected as Limited Distribution Network Partner for Cutaquig®, Octapharma’s new 16.5% Subcutaneous Immune Globulin. SUGAR LAND, TX ( May 29, 2019) - Healix Infusion Therapy is pleased to announce that it has been selected as a limited...
Texas Infectious Diseases Society (TIDS) Annual Meeting
Lost Pines, TX Healix will be attending and exhibiting at the Texas Infectious Diseases Society (TIDS) Annual Meeting on June 7-9., 2019, in Lost Pines, Texas. Come and visit with our team to learn about how we help infectious disease practices like yours to...
Arizona United Rheumatology Alliance (AURA) Annual Meeting
Sedona, AZ Join Healix in sunny Sedona, Arizona, on May 31 - June 2, 2019, for the Arizona United Rheumatology Alliance (AURA) Annual Meeting. Our team would love to meet with you to discuss how Healix can help you establish an office infusion center or outsource...
Georgia Society of Rheumatology (GSR) Annual Meeting
Greensboro, GA Healix is proudly exhibiting at the upcoming Georgia Society of Rheumatology (GSR) Annual Meeting on May 31 - June 2, 2019, at the Ritz-Carlton, Reynols Plantation, in Greensboro, Georgia. If you are considering starting your own infusion program or...
Consortium of Multiple Sclerosis Centers (CMSC) Annual Meeting
Seattle, WA Are you attending the Consortium of Multiple Sclerosis Centers (CMSC) Annual Meeting on May 28 - June 1 in Seattle, Washington? Come visit the Healix booth to discuss our expert infusion management services that we provide to neurologists nationwide. To...
Digestive Disease Week (DDW)
Come and visit with the Healix team at Digestive Disease Week (DDW) on May 19-21, 2019, in San Diego! We would love to meet with you to discuss how a Healix-managed infusion program can help you achieve your goals of exceptional patient care while growing your...
American Academy of Neurology (AAN) Annual Meeting
Join Healix at the 2019 American Academy of Neurology (AAN) Annual Meeting on May 4-8, 2019, in Philadelphia, Pennsylvania. Our team of Healix representatives will be available at our booth to discuss how a Healix-managed infusion program can help you to provide...
Healix Selects Citus Health to Digitally Transform Communication Streams and Care Coordination
Healix, the nation’s leader in providing physician office-based infusion services, will implement the Citus Health digital solution suite to streamline multi-office healthcare communications and automate documentation workflows to provide the highest-quality...
Healix Announces Strategic Partnership with WeInfuse
SUGAR LAND, TX (December 6, 2018) – Healix, the nation's leader in providing physician office-based infusion services, announces a strategic partnership with WeInfuse, the first and only end-to-end workflow software application purpose-built for infusion centers....
Healix Announces Strategic Partnership with DoseMe for Precision Dosing
SUGAR LAND, TX (July 20, 2018) – Healix, the nation’s leader in physician office based infusion services, announced a strategic relationship with DoseMe, a precision dosing decision support platform specifically for clinical practice. “We are really pleased to...
TA Associates Announces Investment in Healix
BOSTON and SUGAR LAND, Texas, December 18, 2017 – TA Associates, a leading global growth private equity firm, today announced that it has completed a strategic growth investment in Healix, a provider of outsourced alternate-site infusion therapy management...
Healix Relocates to New State-of-the-Art Pharmacy Facility in Sugar Land, Texas
SUGAR LAND, TX (July 28, 2017) – Healix Infusion Therapy, Inc. is proud to announce the relocation of its pharmacy operation to a new, state-of-the-art facility in Sugar Land, Texas. With more than 28 years of sterile compounding services, the Healix Infusion...
Healix is Now a National Provider of Trogarzo™ (ibalizumab-uiyk)
SUGAR LAND, TX (July 28, 2017) – Healix® is Now a National Provider of Trogarzo™ (ibalizumab-uiyk). Trogarzo™ is a new humanized monoclonal antibody for the treatment of multidrug-resistant (MDR) HIV-1 infection. This drug has a new mechanism of action and is the...